.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
US Department of Justice
Baxter
Julphar
Daiichi Sankyo
Healthtrust
UBS
Express Scripts
Moodys

Generated: January 17, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Switzerland Patent: 1018/96

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Bristol Myers SquibbREYATAZatazanavir sulfateCAPSULE;ORAL021567-001Jun 20, 2003DISCNYesNo➤ Subscribe➤ SubscribeY
Bristol Myers SquibbREYATAZatazanavir sulfateCAPSULE;ORAL021567-002Jun 20, 2003ABRXYesNo➤ Subscribe➤ SubscribeY
Bristol Myers SquibbREYATAZatazanavir sulfateCAPSULE;ORAL021567-003Jun 20, 2003ABRXYesNo➤ Subscribe➤ SubscribeY
Bristol Myers SquibbREYATAZatazanavir sulfateCAPSULE;ORAL021567-004Oct 16, 2006ABRXYesYes➤ Subscribe➤ SubscribeY
Bristol Myers SquibbREYATAZatazanavir sulfatePOWDER;ORAL206352-001Jun 2, 2014RXYesYes➤ Subscribe➤ SubscribeY
Bristol-myers SquibbEVOTAZatazanavir sulfate; cobicistatTABLET;ORAL206353-001Jan 29, 2015RXYesYes➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist